Off-label Prescribing: Justifying Unapproved Medicine - Cavalla, David (Napp Research Centre, Cambridge, UK) - Books - John Wiley and Sons Ltd - 9781118912072 - February 20, 2015
In case cover and title do not match, the title is correct

Off-label Prescribing: Justifying Unapproved Medicine

Cavalla, David (Napp Research Centre, Cambridge, UK)

Price
NOK 649
excl. VAT

Ordered from remote warehouse

Expected delivery Apr 21 - May 2

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Off-label Prescribing: Justifying Unapproved Medicine

Today s medicines are regulated for their efficacy and safety and, once approved, they can be marketed for certain uses as justified by the data. Regulatory bodies in developed countries are constituted by legal statute and operate as parts of government, ostensibly in the interests of the people as patients.

216 pages

Media Books     Hardcover Book   (Book with hard spine and cover)
Released February 20, 2015
ISBN13 9781118912072
Publishers John Wiley and Sons Ltd
Pages 224
Dimensions 253 × 178 × 16 mm   ·   492 g
Show all

More by Cavalla, David (Napp Research Centre, Cambridge, UK)

See all of Cavalla, David (Napp Research Centre, Cambridge, UK) ( e.g. Hardcover Book )